Newborn and Infant Nursing Reviews
Volume 9, Issue 1 , Pages 48-52 , March 2009

Emerging Trends in Antibiotic Use in Neonates: New or Not-so-New Drugs for New Bugs

References 

  1. Gourley D. Joint Commission places infection control under the microscope. FOCUS. J Respir Care Sleep Med. 2004;
  2. Ryan K, Kenneth J. Sherris Medical Microbiology An Introduction to Infectious Disease. Norwalk CT: Appleton & Lange; 1994;
  3. Isaacs D. Unnatural Selection: reducing antibiotics resistance in neonatal units. Arch Dis Child Fetal Neonatal Ed. 2006;91:F72–F74
  4. Katzung B. Basic and Clinical Pharmacology. Norwalk CT, Appleton & Lange. 1995; 671--692, 699--703.
  5. Remington J, Klein J. Wilson & Bakers Infectious Disease of the Fetus and Newborn Infant. 6th ed.. Elsevier; 2006;
  6. Young T. Aminoglycoside therapy in neonates: with particular reference to gentamicin. Neoreviews. 2002;3:243
  7. Polin RA, Saiman L. Nosocomial Infection in the Neonatal Intensive Care Unit. Neoreviews. 2003;4:e81–e88
  8. Bloom B, Craddock A, Delmore P, et al. Reducing acquired infections in the NICU: observing and implementing meaningful differences in process between high and low acquired infection rate centers. J Perinatol. 2003;23:489–492
  9. Lee NLS, Yuen KY, Kumana CR. Beta lactam antibiotics and beta lactamase inhibitor combinations. JAMA. 2001;285:386–388
  10. Gupta A, Ampofo K, Rubinstein D, Saiman L. Extended spectrum B lactamase-producing Klebsiella pneumoniae infections: a review of the literature. J Perinatol. 2003;23:439–443
  11. Seigel J, Rhinehart E, Jackson M, Chiarello L. Management of Multidrug-Resistant Organisms in Healthcare Settings. CDC; 2006;
  12. Young TE, Mangum B. Neofax. Thomson; 2008;
  13. Garges H, Alexander KA. Pharmacology review: newer antibiotics: imipenem/cilastin and meropenem. Neoreviews. 2003;4:364
  14. Vancocin package insert
  15. Ena J, Dick R, Jones R, Wensel R. The epidemiology of intravenous vancomycin usage in a university hospital: a 10 year study. JAMA. 1993;269:598–602
  16. MMWR. 2004; 53:322--323.
  17. Bracher D. Methicillin resistant Staphylococcus aureus in nurseries. Neoreviews. 2005;6:424–430
  18. Sohn A, Garrett DO, Sinkowitz-Cochran R, et al. Prevalence of nosocomial infections in neonatal intensive care unity patients: results from the first national point-prevalence survey. J Pediatr. 2001;139:821–827
  19. Stoll BJ, Hansen N, Fanaroff AA, et al. Late onset sepsis in very low birth weight neonates: the experience of NICHD Neonatal Research Network. Pediatrics. 2002;110:285–291
  20. Lodha A, Furlan AD, Whyte H, Moore AM. Prophylactic antibiotics in the prevention of catheter-associated bloodstream bacterial infection in preterm neonates: a systematic review. J Perinatol. 2008;28:526–533
  21. Clark R, Powers R, White R, Bloom B, Sanchez P, Benjamin DK. Prevention and treatment of nosocomial sepsis in the NICU. J Perinatol. 2004;24:446–453
  22. Manzella J. Quinupristin-dalfopristin: a new antibiotic for severe gram-positive infection. Am Fam Phys. 2001;11:1863
  23. Garges H, Alexander KA. Pharmacology review: newer antibiotics: linezolid. Neoreviews. 2003;4:128

PII: S1527-3369(08)00170-0

doi: 10.1053/j.nainr.2008.12.008

Newborn and Infant Nursing Reviews
Volume 9, Issue 1 , Pages 48-52 , March 2009